Trial intelligence / Profile preview

Dextromethorphan and Topiramate in Orofacial Neuralgias

NCT00001725Phase 2Completed

Sponsor
National Institute of Dental and Craniofacial Research
Start
Dec 1997
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in trigeminal neuralgia (TN) comparing Dextromethorphan Cohort with Topiramate Cohort (2 cohorts). Primary endpoint: Overall daily pain assessed by Gracely pain intensity descriptors. Started Dec 1997; status: completed.

02

Drugs

dextromethorphantopiramate
03

Conditions

trigeminal neuralgia (TN)

Beyond the preview

Go deeper on NCT00001725.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001725.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call